Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kang, JH | - |
dc.contributor.author | Lee, YY | - |
dc.contributor.author | Yu, BY | - |
dc.contributor.author | Yang, BS | - |
dc.contributor.author | Cho, KH | - |
dc.contributor.author | Yoon, DK | - |
dc.contributor.author | Roh, YK | - |
dc.date.accessioned | 2024-01-21T04:09:09Z | - |
dc.date.available | 2024-01-21T04:09:09Z | - |
dc.date.created | 2021-09-02 | - |
dc.date.issued | 2005-11 | - |
dc.identifier.issn | 0253-6269 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/136034 | - |
dc.description.abstract | Recently, it was reported that reduction in serum adiponectin levels is correlated with the incidence of breast cancer. As an effort to explain this, we screened various human breast cancer cell lines to identify those in which proliferation is directly controlled by adiponectin. Among the five tested cell lines, proliferation of MDA-MB-231 cancer cell was significantly suppressed by adiponectin within the range of physiological concentration. Furthermore, prolonged adiponectin treatment caused cell growth arrest and even apoptosis of MDA-MB-231. This result is the first to show that adiponectin can directly control cancer cell growth and provides a rationale for the theory that reduction in plasma adiponectin levels could be a risk factor for breast cancer. | - |
dc.language | English | - |
dc.publisher | PHARMACEUTICAL SOC KOREA | - |
dc.subject | FATTY-ACID OXIDATION | - |
dc.subject | PLASMA ADIPONECTIN | - |
dc.subject | ENDOMETRIAL CANCER | - |
dc.subject | INSULIN-RESISTANCE | - |
dc.subject | METABOLIC SYNDROME | - |
dc.subject | PROTEIN | - |
dc.subject | ADIPOSE | - |
dc.subject | OBESITY | - |
dc.subject | RISK | - |
dc.subject | ASSOCIATION | - |
dc.title | Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell | - |
dc.type | Article | - |
dc.identifier.doi | 10.1007/BF02978210 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | ARCHIVES OF PHARMACAL RESEARCH, v.28, no.11, pp.1263 - 1269 | - |
dc.citation.title | ARCHIVES OF PHARMACAL RESEARCH | - |
dc.citation.volume | 28 | - |
dc.citation.number | 11 | - |
dc.citation.startPage | 1263 | - |
dc.citation.endPage | 1269 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.identifier.kciid | ART001086890 | - |
dc.identifier.wosid | 000233606000012 | - |
dc.identifier.scopusid | 2-s2.0-28844461156 | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | FATTY-ACID OXIDATION | - |
dc.subject.keywordPlus | PLASMA ADIPONECTIN | - |
dc.subject.keywordPlus | ENDOMETRIAL CANCER | - |
dc.subject.keywordPlus | INSULIN-RESISTANCE | - |
dc.subject.keywordPlus | METABOLIC SYNDROME | - |
dc.subject.keywordPlus | PROTEIN | - |
dc.subject.keywordPlus | ADIPOSE | - |
dc.subject.keywordPlus | OBESITY | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordPlus | ASSOCIATION | - |
dc.subject.keywordAuthor | adiponectin | - |
dc.subject.keywordAuthor | breast cancer | - |
dc.subject.keywordAuthor | MDA-MB-231 | - |
dc.subject.keywordAuthor | growth arrest | - |
dc.subject.keywordAuthor | apoptosis | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.